SXI Life Sciences
|
7 197,72
|
-64,12
|
-0,88 %
|
Analysen zu SXI Life Sciences-Werten
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Roche Neutral | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.05.24 | Roche Hold | Deutsche Bank AG | |
| 24.05.24 | Novartis Buy | Deutsche Bank AG | |
| 23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.05.24 | Roche Neutral | UBS AG | |
| 17.05.24 | Roche Hold | Deutsche Bank AG | |
| 16.05.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 16.05.24 | Roche Hold | Jefferies & Company Inc. | |
| 14.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Roche Neutral | UBS AG | |
| 06.05.24 | Novartis Buy | UBS AG | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.24 | Roche Neutral | UBS AG | |
| 25.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Roche Kaufen | DZ BANK | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.